Jin S. Im

2.7k total citations · 1 hit paper
56 papers, 1.7k citations indexed

About

Jin S. Im is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Jin S. Im has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 18 papers in Oncology and 14 papers in Hematology. Recurrent topics in Jin S. Im's work include Immune Cell Function and Interaction (28 papers), T-cell and B-cell Immunology (23 papers) and CAR-T cell therapy research (10 papers). Jin S. Im is often cited by papers focused on Immune Cell Function and Interaction (28 papers), T-cell and B-cell Immunology (23 papers) and CAR-T cell therapy research (10 papers). Jin S. Im collaborates with scholars based in United States, United Kingdom and Canada. Jin S. Im's co-authors include Steven A. Porcelli, Gurdyal S. Besra, Petr A. Illarionov, Alberto Molano, Karl O. A. Yu, Claire Forestier, Young‐Tae Chang, Yves Dutronc, Gabriel Bricard and Amy R. Howell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Jin S. Im

50 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Histone lactylation drives CD8+ T cell metabolism and function

2024 74 citations Jin S. Im et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jin S. Im United States	22	1.3k	353	233	155	111	56	1.7k
Miguel Relloso Spain	20	731 0.6×	181 0.5×	353 1.5×	138 0.9×	45 0.4×	32	1.2k
Terri K. Wade United States	15	1.1k 0.8×	134 0.4×	259 1.1×	96 0.6×	45 0.4×	24	1.4k
Karl O. A. Yu United States	15	938 0.7×	151 0.4×	176 0.8×	137 0.9×	44 0.4×	25	1.2k
Golo Henning Germany	11	1.1k 0.8×	476 1.3×	316 1.4×	159 1.0×	74 0.7×	11	1.5k
Daniëlle J. E. B. Krooshoop Netherlands	7	1.2k 0.9×	278 0.8×	412 1.8×	77 0.5×	48 0.4×	8	1.4k
Sarah Longworth United States	9	1.4k 1.1×	405 1.1×	312 1.3×	318 2.1×	44 0.4×	15	1.9k
A. Raúl Castaño Spain	16	1.2k 0.9×	156 0.4×	275 1.2×	120 0.8×	32 0.3×	25	1.4k
Adriaan D. Bins Netherlands	19	752 0.6×	451 1.3×	444 1.9×	137 0.9×	43 0.4×	41	1.5k
Pappanaicken R. Kumaresan United States	18	472 0.4×	308 0.9×	350 1.5×	213 1.4×	116 1.0×	57	1.2k
Kate H. Gartlan Australia	21	725 0.5×	230 0.7×	292 1.3×	94 0.6×	306 2.8×	35	1.2k

Countries citing papers authored by Jin S. Im

Since Specialization

Citations

This map shows the geographic impact of Jin S. Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin S. Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin S. Im more than expected).

Fields of papers citing papers by Jin S. Im

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin S. Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin S. Im. The network helps show where Jin S. Im may publish in the future.

Co-authorship network of co-authors of Jin S. Im

This figure shows the co-authorship network connecting the top 25 collaborators of Jin S. Im. A scholar is included among the top collaborators of Jin S. Im based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin S. Im. Jin S. Im is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Edatt, Lincy, Salma H. Azam, Jin S. Im, et al.. (2025). Inverted chimeric RNAi molecules synergistically cotarget MYC and KRAS in KRAS-driven cancers. Journal of Clinical Investigation. 135(19). 1 indexed citations

Zarrin, David, Shivani Baisiwala, Jin S. Im, et al.. (2025). Cost savings associated with a nurse driven mobilization protocol for recovery after cranial tumor resection. Acta Neurochirurgica. 167(1). 237–237.

Ramdial, Jeremy, Laura Di Clemente, Pinaki P. Banerjee, et al.. (2024). Phase II Clinical Trial of “Off-the-Shelf” NK Cells with Allogeneic Stem Cell Transplantation in Patients with High-Risk Myeloid Malignancies. Blood. 144(Supplement 1). 4841–4841.

Alousi, Amin M., Jin S. Im, LaQuisa Hill, et al.. (2024). Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease. Bone Marrow Transplantation. 59(11). 1594–1600. 1 indexed citations

Ciurea, Stefan O., Uday Popat, Jeremy Ramdial, et al.. (2024). Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies. Blood Advances. 8(12). 3237–3245. 2 indexed citations

Al‐Juhaishi, Taha, Yingjun Wang, Denái R. Milton, et al.. (2023). Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant. Bone Marrow Transplantation. 58(9). 1000–1007. 3 indexed citations

Lee, Sung‐Eun, Feng Wang, Koichi Takahashi, et al.. (2023). Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes. Clinical Cancer Research. 29(10). 1938–1951. 7 indexed citations

Im, Jin S., et al.. (2023). P2.11-03 Synergistic Co-Targeting Of MYC And KRAS In Lung Cancer By Novel Ligand-Directed Inverted Chimeric RNAi Molecules. Journal of Thoracic Oncology. 18(11). S360–S361. 1 indexed citations

Kongtim, Piyanuch, Simrit Parmar, Denái R. Milton, et al.. (2018). Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplantation. 54(6). 839–848. 21 indexed citations

10.

Kim, Sang, Vickie R. Shannon, Ajay Sheshadri, et al.. (2017). Th1/17 Cells Are Expanded in Bronchial Alveolar Lavage (BAL) Fluid from Leukemia Patients with Checkpoint Inhibitor-Induced Pneumonitis. Blood. 130. 3588–3588. 2 indexed citations

11.

Im, Jin S., Chantale Bernatchez, Cara Haymaker, et al.. (2016). Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer. PLoS ONE. 11(7). e0160004–e0160004. 27 indexed citations

12.

Reinink, Peter, et al.. (2015). Expression Patterns of Bovine CD1 In Vivo and Assessment of the Specificities of the Anti-Bovine CD1 Antibodies. PLoS ONE. 10(3). e0121923–e0121923. 5 indexed citations

13.

Relloso, Miguel, Tan‐Yun Cheng, Jin S. Im, et al.. (2008). pH-Dependent Interdomain Tethers of CD1b Regulate Its Antigen Capture. Immunity. 28(6). 774–786. 41 indexed citations

14.

Lu, Cheng, Aito Ueno, Jin S. Im, et al.. (2007). Efficient Activation of Vα14 Invariant NKT Cells by Foreign Lipid Antigen Is Associated with Concurrent Dendritic Cell-Specific Self Recognition. The Journal of Immunology. 178(5). 2755–2762. 14 indexed citations

15.

Forestier, Claire, Toshiyuki Takaki, Alberto Molano, et al.. (2007). Improved Outcomes in NOD Mice Treated with a Novel Th2 Cytokine-Biasing NKT Cell Activator. The Journal of Immunology. 178(3). 1415–1425. 72 indexed citations

16.

Rhijn, Ildiko Van, Ad P. Koets, Jin S. Im, et al.. (2006). The Bovine CD1 Family Contains Group 1 CD1 Proteins, but No Functional CD1d. The Journal of Immunology. 176(8). 4888–4893. 59 indexed citations

17.

Yu, Karl O. A., Jin S. Im, Alberto Molano, et al.. (2005). Modulation of CD1d-restricted NKT cell responses by using N- acyl variants of α-galactosylceramides. Proceedings of the National Academy of Sciences. 102(9). 3383–3388. 288 indexed citations

18.

Forestier, Claire, Alberto Molano, Jin S. Im, et al.. (2005). Expansion and Hyperactivity of CD1d-Restricted NKT Cells during the Progression of Systemic Lupus Erythematosus in (New Zealand Black × New Zealand White)F1 Mice. The Journal of Immunology. 175(2). 763–770. 48 indexed citations

19.

Rhijn, Ildiko Van, David C. Young, Jin S. Im, et al.. (2004). CD1d-restricted T cell activation by nonlipidic small molecules. Proceedings of the National Academy of Sciences. 101(37). 13578–13583. 86 indexed citations

20.

Yang, Yang, Aito Ueno, Min Bao, et al.. (2003). Control of NKT Cell Differentiation by Tissue-Specific Microenvironments. The Journal of Immunology. 171(11). 5913–5920. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact